Consolidated Statements of Cash Flows - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018	Dec. 31, 2018
Cash flows from operating activities:
Net loss	$ (4,399,053)	$ (4,086,476)	$ (8,899,462)	$ (6,820,096)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization			7,642,112	6,844,268
Amortization of debt issuance costs	185,795	245,845	383,368	324,382
Stock based compensation expense related to issuance of restricted stock			9,780
Increase (decrease) in cash, cash equivalents, and restricted cash from changes in assets and liabilities:
Other assets			339,402	(398,230)
Accounts payable and accrued liabilities			369,440	1,341,765
Due to affiliates			1,947,316	(152,574)
Net cash provided by operating activities			1,791,956	1,139,515
Cash flows from investing activities:
Purchase of real estate facilities				(78,830,878)
Additions to real estate facilities			(826,351)	(152,275)
Additions to construction in process			(4,617,891)
Deposit on acquisitions of real estate facilities				(500,000)
Net cash used in investing activities			(5,444,242)	(79,483,153)
Cash flows from financing activities:
Proceeds from issuance of non-revolving mortgage debt				46,905,000
Proceeds from issuance of KeyBank Bridge Loans			4,354,545	24,500,000
Principal payments of KeyBank Bridge Loans			(1,000,000)	(6,703,715)
Debt issuance costs			(70,496)	(1,310,067)
Issuance of preferred equity in our Operating Partnership				610,000
Gross proceeds from issuance of common stock			3,030,455	16,011,588
Redemptions of common stock			(63,900)
Offering costs			(352,544)	(1,695,113)
Distributions paid to common stockholders			(2,350,716)	(1,897,646)
Distributions paid to Operating Partnership unitholders			(7,854)	(9,337)
Net cash provided by financing activities			3,539,490	76,410,710
Net change in cash, cash equivalents, and restricted cash			(112,796)	(1,932,928)
Cash, cash equivalents, and restricted cash, beginning of period			11,272,611	10,371,998	$ 10,371,998
Cash, cash equivalents, and restricted cash, end of period	$ 11,159,815	$ 8,439,070	11,159,815	8,439,070	$ 11,272,611
Supplemental disclosures and non-cash transactions:
Cash paid for interest			5,124,884	2,217,091
Interest capitalized			137,146
Additions to debt issuance costs included in accounts payable and accrued liabilities			135,000	51,600
Deposits applied to purchase of real estate				1,000,000
Acquisition costs included in due to affiliates				370,000
Additions to real estate and construction in process in accounts payable and accrued liabilities			1,360,884
Proceeds from issuance of common stock previously in accounts payable and accrued liabilities			73,900	228,000
Offering costs included in accounts payable and accrued liabilities or due to affiliates			588,876	596,600
Non-cash preferred equity issuance in our Operating Partnership				6,100
Distributions payable			1,072,847	558,690
Redemptions of common stock included in accounts payable and accrued liabilities			115,037
Issuance of shares pursuant to distribution reinvestment plan			$ 1,153,657	$ 1,166,710